Centrophenoxine
From Wikipedia, the free encyclopedia
 |
|
|
Centrophenoxine
|
|
| Systematic (IUPAC) name | |
| 2-dimethylaminoethyl 2-(4-chlorophenoxy)acetate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H16ClNO3 |
| Mol. mass | 257.713 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Centrophenoxine (also called Meclofenoxate, and formerly sold under the brand name Lucidril) is a drug used to treat the symptoms of senile dementia and Alzheimer's Disease. It is a compound of two biochemicals: dimethylaminoethanol (DMAE) and parachlorophenoxyacetate (pCPA). DMAE is a natural substance, found especially in fish, and also produced in the human brain. pCPA is a synthetic compound that resembles a variety of plant hormones called auxins.
Like DMAE, it is a precursor to the neurotransmitter acetylcholine and may increase levels of this chemical in the CNS. It is reported to improve memory and general cognition.
It is also used off-label as a nootropic, often combined with a racetam drug such as piracetam. A typical nootropic dose is 250–500mg, 1–3 times per day.
[edit] Side Effects & Contraindications
Possible side effects may include nausea or mild dizziness. People with severely high blood pressure or convulsive disorders such as epilepsy should avoid Centrophenoxine. [1] Large doses may cause tight jaw clenching.
[edit] References
1. Centrophenoxine Page @ The American Academy of Anti-Aging Medicine
[edit] External links
|
|||||||||||||||||||||||
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
